TY - JOUR
T1 - Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registry
AU - Navar, Ann Marie
AU - Wang, Tracy Y.
AU - Goldberg, Anne C.
AU - Robinson, Jennifer G.
AU - Roger, Veronique L.
AU - Wilson, Peter F.
AU - Virani, Salim S.
AU - Elassal, Joesph
AU - Lee, L. Veronica
AU - Webb, Laura E.
AU - Peterson, Eric
N1 - Publisher Copyright:
© 2015 Mosby, Inc.
PY - 2015
Y1 - 2015
N2 - Background Despite improvements in diagnosis and treatment, the prevalence of hyperlipidemia among adults in the United States remains high. Data are limited on treatment patterns and patient perceptions of cardiovascular disease risk since the release of new lipid guidelines. Objectives The objectives of the PALM registry are to assess contemporary patterns of lipid-lowering therapy use among adults receiving care in a nationally representative cohort of community clinics, determine consistency of treatment with varying lipid guidelines, identify factors affecting use of lipid-lowering therapy including patient-reported statin intolerance, and assess patient and provider knowledge of cardiovascular risk reduction goals. Study Design The PALM registry will enroll 7,500 patients likely to be considered for lipid-lowering therapy from 175 cardiology, primary care, and endocrinology practices across the United States. In this cross-sectional, observational registry, a novel tablet-based platform will be used to collect patient-reported knowledge, attitudes, and beliefs regarding cardiovascular risk reduction and lipid management. Chart abstraction and core laboratory lipid levels will describe current lipid management. Provider surveys will assess perception of current lipid-lowering goals and barriers to optimal cardiovascular risk reduction. Conclusion The PALM registry will allow for better understanding of current practice patterns, patient experiences, and patient and provider attitudes toward cholesterol management for cardiovascular disease risk reduction. These data can be used to better understand gaps in care and design targeted interventions to improve uptake of lipid-lowering therapies for cardiovascular risk reduction.
AB - Background Despite improvements in diagnosis and treatment, the prevalence of hyperlipidemia among adults in the United States remains high. Data are limited on treatment patterns and patient perceptions of cardiovascular disease risk since the release of new lipid guidelines. Objectives The objectives of the PALM registry are to assess contemporary patterns of lipid-lowering therapy use among adults receiving care in a nationally representative cohort of community clinics, determine consistency of treatment with varying lipid guidelines, identify factors affecting use of lipid-lowering therapy including patient-reported statin intolerance, and assess patient and provider knowledge of cardiovascular risk reduction goals. Study Design The PALM registry will enroll 7,500 patients likely to be considered for lipid-lowering therapy from 175 cardiology, primary care, and endocrinology practices across the United States. In this cross-sectional, observational registry, a novel tablet-based platform will be used to collect patient-reported knowledge, attitudes, and beliefs regarding cardiovascular risk reduction and lipid management. Chart abstraction and core laboratory lipid levels will describe current lipid management. Provider surveys will assess perception of current lipid-lowering goals and barriers to optimal cardiovascular risk reduction. Conclusion The PALM registry will allow for better understanding of current practice patterns, patient experiences, and patient and provider attitudes toward cholesterol management for cardiovascular disease risk reduction. These data can be used to better understand gaps in care and design targeted interventions to improve uptake of lipid-lowering therapies for cardiovascular risk reduction.
UR - http://www.scopus.com/inward/record.url?scp=84954218324&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2015.08.002
DO - 10.1016/j.ahj.2015.08.002
M3 - Article
C2 - 26542493
AN - SCOPUS:84954218324
SN - 0002-8703
VL - 170
SP - 865
EP - 871
JO - American Heart Journal
JF - American Heart Journal
IS - 5
ER -